The presence of TERT promoter mutations has recently been shown as a unfavorable prognostic factor in a number of cancer types including papillary thyroid carcinoma, glioblastoma, bladder cancer, and others [31, 94–97]. This evidence concerns the gene TERT and urinary bladder cancer.